Rabbit anti-ASPL Antibody Affinity Purified
Product Details
Specifications
The epitope recognized by A302-351A-T maps to a region between residue 175 and 225 of human alveolar soft part sarcoma locus using the numbering given in entry NP_076988.1 (GeneID 79058).
Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4. Antibody was affinity purified using an epitope specific to ASPL immobilized on solid support.
The epitope recognized by A302-351A maps to a region between residue 175 and 225 of human alveolar soft part sarcoma locus using the numbering given in entry NP_076988.1 (GeneID 79058).
Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4.
Additional Product Information
The gene which encodes ASPL (alveolar soft part sarcoma locus) has been identified as a fusion partner of the transcription factor TFE3 in ASPS and renal cell carcinomas.
Alternate Names
alveolar soft part sarcoma chromosomal region candidate gene 1 protein; alveolar soft part sarcoma chromosome region, candidate 1; alveolar soft part sarcoma locus; ASPCR1; ASPL; ASPS; RCC17; renal cell carcinoma gene on chromosome 17; renal cell carcinoma, papillary, 17; renal papillary cell carcinoma protein 17; tether containing UBX domain for GLUT4; TUG; UBX domain protein 9; UBX domain-containing protein 9; UBXD9; UBXN9
Applications
All western blot analysis is performed using 5% Milk-TBST for blocking and as antibody diluent. Primary antibody is incubated overnight.
Western blots of immunoprecipitates are performed using Goat anti-Rabbit Light Chain HRP Conjugate (Cat. No. A120-113P) with 5% Normal Pig Serum (Cat. No. S100-020) added to the blocking buffer.